Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to a loss of $1.09 per share a year ago. These ...
Beam Therapeutics BEAM shares are rising Tuesday after the company reported quarterly results. Beam Therapeutics stock is surging to new heights today. What’s fueling BEAM momentum? Beam Surpasses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results